Skip to main content
Equibles

EVGN · Evogene Ltd.

Track EVGN — free

Use EVGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EVGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.37 +0.00 (+0.98%)
Rebalance outlook locked
Market Cap
$5.81M
Shares
15.80M
Volume · Oct 20 11.12K Avg daily vol (3M) 1.41M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.37 Open$0.39 Day$0.37–0.39 52W close$0.37–1.31 Avg vol 30d2.6M Short int933K · 5.9% float · 1.0d Short vol14% Last earningsAug 18, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Nov 17, 2026 Est · unconfirmed · in 4 wks
Q4 2025 earnings call transcript
call held Mar 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.66M
Trailing 12 months
Net income (TTM)
−$9.07M
Trailing 12 months
Revenue growth YoY
-30.9%
Year over year
Operating margin
-879.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-188.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+33.8%
Year over year · more shares
Price change (1Y)
-70.6%
Trailing year
Short interest
5.9%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −46%
below
Price vs 50-day avg −24%
below
RSI (14) 38
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −24%
trailing
6-month return −51%
trailing
YTD return −66%
this year
Relative strength −59%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
1 of 14 funds reported for Sep 30 · net -8.7K sh shares
Insider flow Accumulating
Net +$692.1K over 90 days · 0% sells
Short interest Rising
5.90% of float · ▲ +1541.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
14 holders — near 3-yr low, contrarian setup
Squeeze score 61
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 80%
annualized · 1-yr
Max drawdown −72%
past year
ATR 11.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−46% Bearish
Price vs 50-day avg
−24% Bearish
RSI (14)
38 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
1 of 14 funds reported for Sep 30 · net -8.7K sh shares
Insider flow Accumulating
Net +$692.1K over 90 days · 0% sells
Short interest Rising
5.90% of float · ▲ +1541.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
14 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $1
vs 200-day avg -46% vs 50-day avg -24%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EVGN
Evogene Ltd.
this stock
$5.81M -66.2% — — 5.9%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.07B +13.5% +46.2% 29.9 1.8%
MRNA
Moderna, Inc.
 $90.58B +720.9% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.51B +4.6% +20.8% 19.4 2.1%
CSLLY
Csl Ltd
 $66.34B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
14
% held
1.7%
Reported
1 of 14
Top holder
HRT FINANCIAL LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
932.7K
Days to cover
1.0d
Change
+875.9K sh
View
Short Volume
Short vol %
14%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
512.8K
Value
$210.2K
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
48.7%
Week of
Sep 14, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$692.1K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 6, 2026
This year
20
View
Exempt Offerings
Offering
$3.4M
Filed
Feb 19, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 18, 2026
View

Performance

5D 20D 120D MTD YTD
EVGN -4.8% -24.2% -51.1% -6.4% -66.2%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -3.6% -23.6% -59.2% -7.3% -79.0%
Key facts CIK 1574565 CUSIP M4119S187 13F (30d) 1 filings 1 filers Visit website Investor relations